The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R‐tetrahydrobiopterin): a phase II, multicentre, open‐label, screening study
- 12 September 2007
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 30 (5), 700-707
- https://doi.org/10.1007/s10545-007-0605-z
Abstract
This study aimed to evaluate the response to and safety of an 8-day course of sapropterin dihydrochloride (6R-tetrahydrobiopterin or 6R-BH4) 10 mg/kg per day in patients with phenylketonuria (PKU), who have elevated blood phenylalanine (Phe) levels, and to identify a suitable cohort of patients who would respond to sapropterin dihydrochloride treatment with a reduction in blood Phe level. Eligible patients were aged ≥ 8 years, had blood Phe levels ≥ 450 μmol/L and were not adhering to a Phe-restricted diet. Suitable patients were identified by a ≥30% reduction in blood Phe level from baseline to day 8 following sapropterin dihydrochloride treatment. The proportion of patients who met these criteria was calculated for the overall population and by baseline Phe level (<600, 600 to <900, 900 to <1200 and ≥1200 μmol/L). In total, 485/490 patients completed the study and 20% (96/485) were identified as patients who would respond to sapropterin dihydrochloride. A reduction in Phe level was observed in all subgroups, although response was greater in patients with lower baseline Phe levels. Wide variability in response was seen across all baseline Phe subgroups. The majority of adverse events were mild and all resolved without complications. Sapropterin dihydrochloride was well tolerated and reduced blood Phe levels across all PKU phenotypes tested. Variability in reduction of Phe indicates that the response to sapropterin dihydrochloride cannot be predicted by baseline Phe level.Keywords
This publication has 16 references indexed in Scilit:
- Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuriaMolecular Genetics and Metabolism, 2005
- Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: A pilot studyMolecular Genetics and Metabolism, 2005
- Response of patients with phenylketonuria in the US to tetrahydrobiopterinMolecular Genetics and Metabolism, 2005
- High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1919 patients observed from 1988 to 2002Molecular Genetics and Metabolism, 2002
- Tetrahydrobiopterin as an Alternative Treatment for Mild PhenylketonuriaThe New England Journal of Medicine, 2002
- How practical are recommendations for dietary control in phenylketonuria?The Lancet, 2002
- National Institutes of Health Consensus Development Conference Statement: Phenylketonuria: Screening and Management, October 16–18, 2000PEDIATRICS, 2001
- Tetrahydrobiopterin Responsiveness in Phenylketonuria Differs between Patients with the Same GenotypeMolecular Genetics and Metabolism, 2001
- Unsolved problems in diagnosis and therapy of hyperphenylalaninemia caused by defects in tetrahydrobiopterin metabolismThe Journal of Pediatrics, 1986
- Effect of Age at Loss of Dietary Control on Intellectual Performance and Behavior of Children with PhenylketonuriaThe New England Journal of Medicine, 1986